Prescribers & Dispensers Schedule
The OUD ECHO Prescriber & Dispensers is an online Tele ECHO program designed to connect primary care teams with inter-disciplinary specialist teams to spread knowledge, on how to manage, treat and provide best care practice for complex chronic health conditions with a focus on addiction, and opioid use disorder (OUD) diagnosis.
This ECHO clinic begins January 11, 2023 through December 13, 2023 and will meet every other Wednesday from 12pm to 1:30pm EST. There is no cost to join, and you can earn free continuing education credits (CME). You can register for this clinic now:
Would you like feedback and recommendations on how to treat and manage a patient’s diagnosis? De-identified case presentations from participants are key parts of an ECHO clinic. You can submit a confidential, de-identified case by using this Qualtrics survey.
Schedule: 2023 Curriculum
Date | Topic | Presentation |
---|---|---|
Jan 11, 2023 | Introduction to MAT | View |
Jan 25, 2023 | Overview of Medicated Assisted Treatment & Data Waiver Requirements | View |
Feb 8, 2023 | Pharmacist Role in MAT | View |
Feb 22, 2023 | How OUD & MAT affects the Brain Chemistry | View |
March 8, 2023 | What's New in Pain and Addiction Treatment or The Novel Drug | View |
March 22, 2023 | Peer Recovery Indiana Pregnancy Program |
View
View |
April 5, 2023 | Legal Issues Facing Those with OUD | View |
April 19, 2023 | Opioid Addiction Risk in Chronic Pain Patients | View |
May 3, 2023 | Precipitative Withdraw and Induction | View |
May 17, 2023 | Overdose Awareness and Prevention | View |
May 31, 2023 | Understanding and Treating Hepatitis C in Patients Who Use Drugs | View |
June 14, 2023 | Behavioral Traits linked to Addiction - Neuro imaging
- Participate in amazing futuristic study and receive compensation |
View
VR Flyer Participate |
June 28, 2023 | Psychosis/ Mania and Amphetamine Use | View |
July 12, 2023 | Recovery Capital in MAT | View |
July 26, 2023 | Drug Testing/Patient Agreements & Non-compliance | View |
August 9, 2023 | Education Updates for a DEA holders (new MATE Act) | View |
August 23, 2023 | Stigma in OUD Medications | View |
September 6, 2023 | Psychedelics For Treatment of Use Disorders | View |
September 20, 2023 | No Session | |
October 4, 2023 | Ketamine in OUD | View |
October 18, 2023 | Medical Records Documentation | View |
November 1, 2023 | Harm Reduction | View |
November 15, 2023 | Xylazine origin, and effects with opioid use disorder | |
November 22, 2023 | Holiday | |
November 29, 2023 | Use of Subclade vs Sublingual | |
December 13, 2023 | Removing the Stigma from Substance Use Disorder | |
December 27, 2023 | Holiday |
Past Sessions (Jan 2022 - Dec 2022)
Date | Topic | Presentation |
---|---|---|
1/5/2022 | Introduction to MAT | View |
1/12/2022 | The Role of a Pharmacist in MAT | View |
1/19/2022 | Overview of Medicated Assisted Treatment & Data Waiver Requirements | View |
1/26/2022 | Peer Recovery | View |
2/2/2022 | Drug Testing/Patient Agreements/Non-compliance | View |
2/9/2022 | Overview of Cognitive Behavior Therapy and DBT | View |
2/16/2022 | Vivitrol and its Use | View |
2/23/2022 | SUD in LGBTQ/OUD SUD Stigma | View |
3/2/2022 | How OUD & MAT affects the Brain Chemistry | View |
3/9/2022 | Overdose Lifeline -Short Guide to Harm Reduction | View |
3/16/2022 | The latest Street Drugs; How to Detect; How to Treat; What are They Called | View |
3/23/2022 | Peer Recovery Coach | View |
3/30/2022 | Compliance & Monitoring Patients with OUD | View |
4/6/2022 | AAA Program - Update on Diagnosis, Assessment and Treatment of Alcohol Use Disorder | Part 1 Part 2 |
4/13/2022 | Suicide risk assessment | View Flyer |
4/20/2022 | Addressing Women and Addiction | View |
4/27/2022 | Recovery Capital | View Scale |
5/4/2022 | Introduction to MAT | View |
5/11/2022 | Landlord Mitigation Reserve program / Recovery House & Oxford House | Part 1 Part 2 Part 3 |
5/18/2022 | Chronic Pain and OUD | View |
5/25/2022 | Pharmacist Role in OUD | View |
6/1/2022 | Pain management and Buprenorphine | View |
6/8/2022 | Legal Issues in OUD and Resources for Pregnant Women with OUD In and Out of Incarceration | Part 1 Part 2 |
6/15/2022 | Drug Testing/Patient Agreements/Non-compliance & Landlord Mitigation | Part 1 Part 2 |
6/22/2022 | Addiction Therapy in Primary Care when patients won’t receive Counseling or MAT | View |
6/29/2022 | Harm Reduction Strategies | Part 1 Part 2 |
7/6/2022 | Weaning MAT | View |
7/13/2022 | Overview of Cannabinoids | View |
7/20/2022 | Use of Subclade vs Sublingual | View |
7/27/2022 | Peer Recovery Coaching | View |
8/3/2022 | Psychosis and Amphetamine Use | View |
8/10/2022 | OUD Affect on Brain Chemistry | View |
8/17/2022 | Harm Reduction Strategies | View |
8/24/2022 | Tobacco Use Disorder | View |
8/31/2022 | How to Prepare for a DEA Audit | View |
9/7/2022 | Stigma & Racial Disparities in Treatment of OUD | View |
9/14/2022 | MAT in the ED, Meth and More | View |
9/21/2022 | Common Drug Trends, Treatment in ED Settings Tyler Stepsis | View |
9/28/2022 | 988 Suicide & Crisis Lifeline | View |
10/5/2022 | [No session this week] | |
10/12/2022 | Tracking and monitoring of controlled substance handling within the healthcare setting | View |
10/19/2022 | Office-Based Management of Opioid USE Disorder (OUD): Evaluation of New Patients for Opioid Agonist Treatment (OAT) | View |
10/26/2022 | The Use (Misuse) of Gabapentin with SUD/OUD | View |
11/2/2022 | Psychosis and Amphetamine Use | View |
11/9/2022 | Legal Issues in OUD | View |
11/16/2022 | Strategies to Wean from MAT How long and discontinuation strategies for buprenorphine | View |
11/23/2022 | [No session this week] | |
11/30/2022 | Acute Pain in OUD | View |
12/7/2022 | ADHD Bipolar Disorder Methamphetamine Use Disorder | View |
12/14/2022 | Crisis Intervention | View |
12/21/2022 | [No session this week] | |
12/28/2022 | [No session this week] |
Past Sessions (Sep 2021 - Dec 2021)
Date | Topic | Presentation |
---|---|---|
9/1/2021 | CBD & the Endocannabinoid System | View |
9/8/2021 | Tobacco Use Disorder | View |
9/15/2021 | Engaging Adolescents in Treatment: Motivational Interviewing | View |
9/22/2021 | Recovery Assist | View |
9/29/2021 | Harm Reduction | View |
10/6/2021 | MAT and Buprenorphine induction | View |
10/13/2021 | Neurobiology | View |
10/20/2021 | Pharmacist Role in MAT | View |
10/27/2021 | Pharmacology | View |
11/3/2021 | Drug Trends | View |
11/10/2021 | Methamphetamine withdrawal and psychosis | View |
11/17/2021 | Harm Reduction | View |
11/24/2021 | [No session this week] | |
12/1/2021 | Hidden drugs of abuse | View |
12/8/2021 | Novel Drugs | View |
12/15/2021 | TBD | |
12/22/2021 | [No session this week] | |
12/29/2021 | [No session this week] |
Past Sessions (Sept 2020 - Aug 2021)
Date | Topic | Presentation |
---|---|---|
9/30/2020 | Medications used for Alcohol Use Disorder | View |
10/7/2020 | Legal Issues Related to OUD | View |
10/14/2020 | [NO SESSION] | |
10/21/2020 | How to treat OUD in patients with Traumatic Brain Injuries | View |
10/28/2020 | Best Practices for SUD by Managed Care Companies | View |
11/4/2020 | Treatments for Tobacco Use Disorder | View |
11/11/2020 | Harm Reduction Strategies | View |
11/18/2020 | Behavioral Health Interventions | View |
11/25/2020 | [NO SESSION] | |
12/2/2020 | Peer Recovery Coaching | View |
12/9/2020 | Addressing Pain Management in OUD Patients | View |
12/16/2020 | OUD & Suicide Risks | View |
1/6/2021 | Indiana Recovery Housing Resources | N/A |
1/13/2021 | Adverse Childhood Experiences | Position Statement |
1/20/2021 | Pharmacists Role in the Treatment of OUD | View |
1/27/2021 | Connection of Human Trafficking to SUD | Position Statement |
2/3/2021 | Treating OUD in Primary Care Offices | View |
2/10/2021 | Addressing Psychiatric Concerns in Primary Care Offices | View |
2/17/2021 | General Overview of Stimulant Use Disorder and Affects on the Brain | View |
2/24/2021 | Pharmacotherapy of Treating Stimulant Use Disorder and Stimulant Withdrawal | View |
3/3/2021 | Treatment of Chronic Psychosis from Stimulants & Behavioral Interventions | View |
3/10/2021 | Acute and Chronic Complications of Methamphetamine Use | View |
3/17/2021 | Prescription Stimulant Abuse | [Not Available] |
3/24/2021 | Contingency Management for the Treatment of Methamphetamine Use Disorder | View |
3/31/2021 | Withdrawal and Cognitive Impairment of Opioid Use Disorder | View |
4/7/2021 | [No Session] | |
4/14/2021 | Legal Issues Related to OUD | View |
4/21/2021 | Motivational Interviewing | View |
4/28/2021 | Harm Reduction Strategies | View |
5/5/2021 | Psychiatric Co-morbidities | View |
5/12/2021 | Stigma Reduction | View |
5/19/2021 | Overview of Medications used for the Treatment of OUD | View |
5/26/2021 | Non-pharmacological Treatment of OUD | View |
6/2/2021 | Long-acting Injectable Buprenorphine | View |
6/9/2021 | Induction of Medications to Treat OUD | View |
6/16/2021 | Buprenorphine Weaning and Tapering | View |
6/23/2021 | Compliance & Monitoring Patients with OUD | View |
6/30/2021 | Resiliency and Provider Self Care | View |
7/7/2021 | [No session this week] | |
7/14/2021 | Peer Support and Regional Recovery Hubs | View |
7/21/2021 | Behavioral Health Interventions | View |
7/28/2021 | Overview of Sythetic Cannabinoids | View |
8/4/2021 | Pharmacists Role in Treatment OUD | View |
8/11/2021 | Treatment in ED Settings | View |
8/18/2021 | Treating Pain in Patients with OUD | View |
8/25/2021 | Indiana Resources | View |
Past Sessions (Feb 2020 - Sept 2020)
Date | Topic | Presentation |
---|---|---|
February 12 | Overview of MAT & Data Waiver | View |
February 19 | Assessment of OUD | View |
February 26 | Induction of MAT | View |
March 4 | How OUD & MAT affect the brain | View |
March 11 | Drug Testing/Patient agreement/non-compliance | View |
March 18 | How to Prepare for DEA Audit | View |
March 25 | SUD and COVID-19 | View |
April 1 | Harm Reduction Strategies | View |
April 8 | Telehealth | View |
April 15 | Pharmacists Role in OUD | View |
April 22 | COVID-19 MAT Prescribing Guidance | View |
April 29 | ASAM COVID Resources | View |
May 6 | Methamphetamines | View |
May 13 | Peer Recovery Network - COVID Resources | View |
May 20 | Compassionate Weaning of Opioids for Pain | View |
May 27 | Sleep Hygiene | View |
June 3 | Common Drug Trends | View |
June 10 | Anxiety and SUD | View |
June 17 | Motivational Interviewing 2.0 | View |
June 24 | When and How to Taper Medications for OUD | View |
July 1 | [No session] | |
July 8 | NAMI Mental Health Resources | View |
July 15 | Overview of Drug and Specialty Courts | View |
July 22 | Overview and Induction of Medications used to treat OUD | View |
July 29 | Long acting injectable Buprenorphine | View |
August 5 | Treatment of OUD in those with Traumatic Brain Injuries | View |
August 12 | Integrated Care Approach to treating OUD | View |
August 19 | Screening for Traumatic Brain Injuries | View |
August 26 | Compliance and Monitoring Patients on Medicated Assisted Treatment | View |
September 2 | Overdose Awareness and Prevention | View |
September 9 | A Case of Family Addiction - Effects on the Child | View |
September 16 | INSPECT Updates – Indiana’s Prescription Monitoring Program | N/A |
September 23 | Functional Analysis and other Behavioral Health Screening Tools | View |
Past Sessions (Sept 2019 - Feb 2020)
Date | Topic | Presentation |
---|---|---|
September 25 | Overview of MAT & Data Waiver | View |
October 2 | Assessment of OUD | View |
October 9 | Induction of MAT | View |
October 16 | [No clinic scheduled this week] | |
October 23 | Methampetamines | View |
October 30 | [No clinic scheduled this week] | |
November 6 | Drug Testing/Patient agreement/non-compliance | View |
November 13 | HIV & Hep C Testing and Screening | View |
November 20 | Treatment in the Emergency Dept Setting | View |
December 4 | SBIRT - Screening, Brief Intervention, Referral to Treatment | View |
December 11 | Indiana Resources | View |
December 18 | Indiana Rural Health Association Opioid Consortium | View |
January 8 | CBD & the Endocannabinoid System | View |
January 15 | Cognitive Behavioral Therapy | View |
January 22 | Recovery Works | View |
January 29 | Self Care and Compassion Fatigue | View |
February 5 | OUD & Suicide | View |
Past Sessions (May 2019 - Sept 2019)
Date | Topic | Presentation |
---|---|---|
May 29 | Overview of Medication-Assisted Treatment & Data Waiver | Part 1 Part 2 |
June 5 | Assessing and Diagnosing OUD | View |
June 12 | Induction to MAT | View |
June 19 | Drug Testing/Patient Agreements/Non-Compliance | View |
June 26 | Neurobiology of OUD & MAT | View |
July 10 | Stigma Reduction | View |
July 17 | Legal Issued Related to OUD Patients | View |
July 24 | Peer Recovery Support Services | View |
August 7 | Harm Reduction Strategies | View |
August 14 | Tobacco Cessation | View |
August 21 | OUD in Pregnancy | View |
August 28 | Addressing Chronic Pain in Patients with OUD | View |
September 4 | Behavioral Interventions | View |
September 11 | Co-Occurring Mental Health Conditions | View |
September 18 | American Society of Addiction Medicine (ASAM) Guidelines | View |